Brain therapy for PTSD reports 68 percent remission in trials
In short
- The treatment, Magnetic e-Resonance Therapy (MeRT), was developed by Wave Neuroscience in California.
- It has been newly cleared by the US Food and Drug Administration.
- The 68 percent remission figure comes from clinical trials, and the source compares it with approved medications.
Why it's good news
The source reports 68 percent remission in clinical trials for MeRT, a personalised form of brain stimulation. It compares this with approved PTSD medications, which top out at around 10.9 percent. Trial results are not the same as everyday use, so the figure needs confirming in wider treatment.
From The Optimist Daily
Image alt text: Patient receiving transcranial magnetic stimulation therapy for PTSD treatment in a clinical setting A newly FDA-cleared treatment for PTSD reported 68 percent remission in clinical trials. The best-performing approved medications for the condition top out at around 10.9 percent. The treatment, called Magnetic e-Resonance Therapy (MeRT), was developed by California-based Wave Neuroscience [โฆ] The post Personalized brain therapy hits 68 percent remission for PTSD first appeared on The Optimist Daily: Making Solutions the News .